A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study

CompletedOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Glycemic ControlSurgical Site InfectionsCardiac ComplicationsLength of StayCost
Interventions
DRUG

standard insulin protocol post-op (continuous IV insulin)

concurrent, matched cohort study of moderate postoperative glucose control in patients undergoing LEB or open AAA repair.Propensity score matching is a statistical method used to reduce the confounding effects of covariates in an observational (non-randomized) study. In practice we will select a number of variables that impact wound infection; age, gender, diabetic and non-diabetic populations, renal insufficiency (defined at creatinine ≥1.8) and indication for surgery (claudication or critical limb ischemia with rest pain or tissue loss or open AAA repair); and chose a group of patients in the Vascular Study Group matched for these variables who have not been treated with an insulin infusion). Consecutive patients undergoing elective open AAA repair or infrainguinal LEB for claudication and critical limb ischemia will be invited to enroll in the study.

Trial Locations (1)

05401

Fletcher Allen Health Care, Burlington

All Listed Sponsors
lead

University of Vermont Medical Center

OTHER

NCT01916733 - A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study | Biotech Hunter | Biotech Hunter